Impact of the COVID-19 pandemic on risk of sarcopenia: From lockdown and infection perspectives: A systematic review and meta-analysis.

Publication date: Aug 09, 2024

During the new coronavirus disease 2019 (COVID-19) pandemic, there are numerous symptoms in the skeletal muscular system, such as decreased skeletal muscle mass, strength, and muscle function, which are the main manifestations of sarcopenia. To investigate the impact of the COVID-19 pandemic on sarcopenia from the perspectives of COVID-19 pandemic lockdown and COVID-19 infection, we conducted this study. We searched for literature related to COVID-19 and sarcopenia published in PubMed, Embase, Cochrane Library, and Web of Science. Two researchers independently searched and screened the articles, extracted data, and assessed the quality of the final included literature. RevMan 5. 4 was used for meta-analysis. A total of 8 articles with a total of 1145 patients were included. There was a significant difference in SARC-F scores (MD = 0. 67, 95%CI = [0. 41, 0. 93], Z = 5. 00, P 

Concepts Keywords
Coronavirus COVID-19
Library Hand Strength
Pandemic Humans
Pubmed Pandemics
Quarantine
Risk Factors
Sarcopenia
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH sarcopenia
disease MESH infection
disease IDO quality
disease MESH Long Covid

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *